Dechra Pharmaceuticals PLC — Director's Dealing 2020

Jun 11, 2020

National Storage Mechanism | Additional information

RNS Number : 7295P

Dechra Pharmaceuticals PLC

11 June 2020

11 June 2020

Dechra Pharmaceuticals PLC

(the Company)

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 11 June 2020 Alison Platt, Non-Executive Director, purchased 760 ordinary shares in the Company.

Following this acquisition, Alison Platt's beneficial interest in the Company is 760 shares (0.001% of the current issued share capital).

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

1.	Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")
a)	Name	Alison Platt
2.	Reason for the notification
a)	Position/status	Director
b)	Initial notification/ amendment	Initial Notification
3.	Details of the Issuer
a)	Name	Dechra Pharmaceuticals PLC
b)	LEI code	213800J4UVB5OWG8VX82
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB0009633180
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volumes(s)	Price(s) £26.090250	760
d)	Aggregated information -    Aggregate volume -    Price -    Total	760 £26.090250 £19,828.59
e)	Date of the transaction	2020-06-11
f)	Place of the transaction	London Stock Exchange

For further information, please contact:

Melanie Hall, Company Secretary                            

Telephone number: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHKKDBPPBKDAAD